COVID-19 study quantifies antibody response to Pfizer, Moderna vaccines (IMAGE)
Caption
Researcher Jeffrey Wilson, MD, PhD, is an immunologist at UVA Health. He and his team found that antibody levels in recipients of the Moderna vaccine were slightly higher than in recipients of Pfizer.
Credit
UVA Health
Usage Restrictions
May be used to accompany news coverage of the antibody study. All other uses require express written permission from UVA Health.
License
Original content